Brain Cancer Trial, Recruiting NCT03343873 Sponsor: Beijing Tiantan Hospital Condition: Brain Cancer
Back to Brain Cancer

Brain Cancer Trial, Recruiting

NCT03343873
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Men between 18 and 65 years old
  • Either healthy volunteers or people who have been diagnosed with a brain tumor
  • People who have completed senior high school or a higher level of education
  • People who are willing and able to sign a consent form agreeing to take part

Who may not be able to join:

  • People who have a medical reason why they cannot have an MRI scan, such as having a metal implant or device inside their body
  • People who have serious health conditions affecting the heart, lungs, liver, kidneys, or other major organ systems
  • People who have a history of major surgery or complications related to anesthesia
  • People with a history of drug misuse or alcohol dependence
  • People who have had an allergic reaction to a study drug in the past (confirm with trial site for details on which drug this refers to)
  • People who experience severe anxiety or fear in enclosed spaces (claustrophobia)
  • People who are left-handed

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Ruquan Han, M.D., Ph.D, Department of Anesthesiology, Beijing Tiantan Hospital

Phone: 8610-67096660

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Beijing Tiantan Hospital
Registry
ClinicalTrials.gov
Start date
1 April 2017
Est. completion
31 December 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Amplitude of Low Frequency Fluctuations(ALLF)and Regional Homogeneity(ReHo)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov